Community-Acquired Pneumonia in HIV-Infected Individuals (Q42235608)

19 October 2017

1 reference

title

Community-Acquired Pneumonia in HIV-Infected Individuals (English)

1 reference

19 October 2017

1 reference

James Brown

1

1 reference

19 October 2017

Marc Lipman

series ordinal

2

1 reference

19 October 2017

publication date

1 March 2014

1 reference

Current infectious disease reports

19 October 2017

published in

1 reference

19 October 2017

volume

16

1 reference

19 October 2017

issue

3

1 reference

19 October 2017

page(s)

397

1 reference

An official ATS workshop report: Emerging issues and current controversies in HIV-associated pulmonary diseases

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

HIV-associated bacterial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Pulmonary infections in HIV-infected patients: an update in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Severe bacterial non-aids infections in HIV-positive persons: incidence rates and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Etiology of pulmonary complications of human immunodeficiency virus-1-infected patients in Taiwan in the era of combination antiretroviral therapy: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Opioid Drug Abuse and Modulation of Immune Function: Consequences in the Susceptibility to Opportunistic Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Dynamics of pneumococcal transmission in vaccine-naive children and their HIV-infected or HIV-uninfected mothers during the first 2 years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Incidence, timing, and determinants of bacterial pneumonia among HIV-infected patients: data from the ICONA Foundation Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Incidence of and risk factors for community acquired pneumonia in US HIV-infected children, 2000-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

The immunomodulatory effects of statins in community-acquired pneumonia: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Assessing the predictive value of HIV indicator conditions in general practice: a case-control study using the THIN database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Monocyte and macrophage dysfunction as a cause of HIV-1 induced dysfunction of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Bronchoalveolar CD4 T cell responses to respiratory antigens are impaired in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Impaired CD4 T cell memory response to Streptococcus pneumoniae precedes CD4 T cell depletion in HIV-infected Malawian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Dendritic cell dysregulation during HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

CD4- and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

CD8 T cells and risk for bacterial pneumonia and all-cause mortality among HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Oral and airway microbiota in HIV-infected pneumonia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Viral pathogens including human metapneumovirus are the primary cause of febrile respiratory illness in HIV-infected adults receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Respiratory syncytial virus (RSV) community-acquired pneumonia (CAP) in a hospitalized adult with human immunodeficiency virus (HIV) mimicking influenza A and Pneumocystis (carinii) jiroveci pneumonia (PCP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Influenza A H1N1 in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Influenza and HIV: Lessons from the 2009 H1N1 Influenza Pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Pandemic H1N12009 influenza and HIV: a review of natural history, management and vaccine immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

HIV-protease inhibitors block the replication of both vesicular stomatitis and influenza viruses at an early post-entry replication step

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Predictors of Pneumonia Severity in HIV-Infected Adults Admitted to an Urban Public Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Guidelines for the management of adult lower respiratory tract infections - Full version

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Invasive pneumococcal disease in HIV-infected adults in France from 2000 to 2011: antimicrobial susceptibility and implication of serotypes for vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

CD4 cell counts and HIV-RNA levels do not predict outcomes of community-acquired pneumonia in hospitalized HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Pneumonia and influenza hospitalization in HIV-positive seniors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Factors associated with smoking in HIV-infected patients and potential barriers to cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV- positive patients in Johannesburg, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Safety and Tolerability of Varenicline Tartrate (Champix®/Chantix®) for Smoking Cessation in HIV-Infected Subjects: A Pilot Open-Label Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Rapid loss of specific antibodies after pneumococcal vaccination in patients with human immunodeficiency virus-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Immunization against pneumococcal disease in HIV-infected patients: conjugate versus polysaccharide vaccine before or after reconstitution of the immune system (CTN-147).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine infant pneumococcal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0397-X

The effect of statin therapy on pneumonia in an HIV-infected population in the Netherlands

21 January 2018

1 reference

12 December 2020

Smoking behaviors in a community-based cohort of HIV-infected indigent adults

1 reference

12 December 2020

Streptococcus pneumoniae colonization among patients with human immunodeficiency virus-1 who had received 23-valent polysaccharide pneumococcal vaccine

1 reference

12 December 2020

An audit of pneumococcal and hepatitis vaccination in an outpatient HIV clinic

1 reference

12 December 2020

A Case of Respiratory Syncytial Virus Infection in an HIV-Positive Adult

1 reference

12 December 2020

Invasive pneumococcal disease in HIV Infected adults. Clinical changes after the introduction of the pneumococcal conjugate vaccine in children

1 reference

12 December 2020

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

1 reference

12 December 2020

HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011.

1 reference

12 December 2020

British HIV Association guidelines for immunization of HIV-infected adults 2008

1 reference

12 December 2020

Risk Factors for Pneumococcal Nasopharyngeal Colonization Before and After Pneumococcal Conjugate Vaccination in Persons with HIV: Brief Report

1 reference

12 December 2020

10.1007/S11908-014-0397-X

Identifiers

DOI

1 reference

19 October 2017

1 reference